Caribou Biosciences, Inc. (CRBU) Financials

CRBU Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 149.0 million 47.0 million
Dec. 31, 2025 179.6 million 57.5 million
Sept. 30, 2025 195.0 million 53.1 million
June 30, 2025 220.9 million 54.8 million

CRBU Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -27.1 million 2.4 million
Dec. 31, 2025 -20.6 million 2.7 million
Sept. 30, 2025 -25.3 million 2.9 million
June 30, 2025 -28.7 million 3.1 million

CRBU Net Income

No data available :(

CRBU Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 117.6 million - 25.7 million
Dec. 31, 2025 139.3 million - 26.0 million
Sept. 30, 2025 147.3 million - 22.8 million
June 30, 2025 183.9 million - 25.9 million

CRBU Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 95.9 million
Dec. 31, 2025 94.5 million
Sept. 30, 2025 93.3 million
June 30, 2025 93.0 million

CRBU Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 72000 20.6 million 8.1 million -
Dec. 31, 2025 216000 23.8 million 8.6 million -
Sept. 30, 2025 115000 22.4 million 9.2 million -
June 30, 2025 418000 27.7 million 10.4 million -

CRBU Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 2.4 million 649000
Dec. 31, 2025 3.9 million 682000
Sept. 30, 2025 2.2 million 631000
June 30, 2025 2.7 million -

CRBU Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CRBU

Price: $1.67

52 week price:
1.04
3.54

Earnings Per Share: -1.42 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 355500

Market Capitalization: 190.4 million

Links: